Administrative Core

行政核心

基本信息

  • 批准号:
    8433280
  • 负责人:
  • 金额:
    $ 18.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-15 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

Exaggerated cardiovascular risk is arguably the most pressing clinical problem facing nephrologists and their patients. The causes of this preponderance of cardiovascular disease in patients with kidney disease are not clear, but hypertension amplifies cardiovascular risk and promotes progression of chronic kidney disease irrespective of the primary cause. Accordingly, the major objective of the George M. O'Brien Kidney Research Core Center at Duke is to promote and support research into understanding the unique links between the kidney, cardiovascular disease, and hypertension. The Administrative Core will be responsible for the overall administrative oversight for the Center. The Director, Dr. Thomas Coffman, will have primary responsibility for coordinating day-to-day operations. He will be assisted by the Associate Director and Center Administrator. Primary governance of the Center will be provided by an Executive Committee consisting of the Center Director, Associate Director, the Core Directors, Chair of the Pilot and Feasibility Program, and Coordinator of the Enrichment Program. The Specific Aims of the Administrative Core are: (1) Provide general oversight of Core operations and performance; (2) Review and assign priorities to proposals for use of Core services, including: (a) establishing investigator eligibility, (b) determining scientific priorities, and (c) determining overall priorities for use of Core services; (3) Implement modifications in Core services based on development of new technologies or services, sub-optimal performance of existing technologies or services, and/or economic factors; (4) Promote interactions between the cores with an emphasis on transitioning discoveries from basic discovery projects to clinical and translational programs, (5) Assessing adequacy of resource allocation; (6) Oversight for pilot and feasibility studies to explore new areas of research relevant to the kidney in cardiovascular diseases serving as a foundation for other external funding. These funds will support new investigators, and will be used to entice senior investigators to address key issues in this thematic area; and (7) Develop education programs designed to highlight the importance of the interrelationship of kidney and cardiovascular disease, to inform Center investigators of the latest advances in relevant research, and to train investigators in clinical and basic science approaches to advance research.
夸张的心血管风险可以说是肾脏病医生及其患者面临的最紧迫的临床问题。肾脏疾病患者中这种心血管疾病优势的原因尚不清楚,但是高血压会扩大心血管风险,并促进慢性肾脏疾病的进展,而与主要原因无关。因此,杜克大学乔治·奥布莱恩肾脏研究核心中心的主要目标是促进和支持研究,以了解肾脏,心血管疾病和高血压之间的独特联系。行政核心将负责该中心的整体行政监督。董事托马斯·科夫曼(Thomas Coffman)博士将负责协调日常运营。他将得到副主任兼中心管理员的协助。该中心的主要治理将由执行委员会提供,由中心主任,副主任,核心主任,试点和可行性计划主席以及Enrichment计划的协调员提供。行政核心的具体目的是:(1)对核心操作和绩效提供一般监督; (2)审查并将优先级分配给使用核心服务的建议,包括:(a)建立研究人员资格,(b)确定科学优先级,以及(c)确定使用核心服务的总体优先级; (3)基于新技术或服务的开发,现有技术或服务的次优绩效以及/或经济因素实施核心服务的修改; (4)促进核心之间的互动,重点是从基本发现项目到临床和转化计划的过渡发现,(5)评估资源分配的充分性; (6)对试点和可行性研究的监督,以探讨与心血管疾病中肾脏有关的新研究领域,这是其他外部资金的基础。这些资金将支持新的调查人员,并将用于吸引高级调查人员解决这个主题领域的关键问题; (7)制定旨在强调肾脏和心血管疾病相互关系的重要性,以告知中心研究人员相关研究的最新进展,并培训研究人员采用临床和基础科学方法进行进步研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS M COFFMAN其他文献

THOMAS M COFFMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS M COFFMAN', 18)}}的其他基金

Paracrine Control of Blood Pressure by Renal Intercalated Cells
肾闰细胞对血压的旁分泌控制
  • 批准号:
    9070607
  • 财政年份:
    2015
  • 资助金额:
    $ 18.05万
  • 项目类别:
George M. O'Brien Kidney Research Core Centers
乔治·M·奥布莱恩肾脏研究核心中心
  • 批准号:
    8385010
  • 财政年份:
    2012
  • 资助金额:
    $ 18.05万
  • 项目类别:
George M. O'Brien Kidney Research Core Centers
乔治·M·奥布莱恩肾脏研究核心中心
  • 批准号:
    8912150
  • 财政年份:
    2012
  • 资助金额:
    $ 18.05万
  • 项目类别:
George M. O'Brien Kidney Research Core Centers
乔治·M·奥布莱恩肾脏研究核心中心
  • 批准号:
    8529521
  • 财政年份:
    2012
  • 资助金额:
    $ 18.05万
  • 项目类别:
Genetic Determinants of Susceptibility to Kidney Disease in African Americans
非裔美国人肾病易感性的遗传决定因素
  • 批准号:
    7936333
  • 财政年份:
    2009
  • 资助金额:
    $ 18.05万
  • 项目类别:
Genetic Determinants of Susceptibility to Kidney Disease in African Americans
非裔美国人肾病易感性的遗传决定因素
  • 批准号:
    7820192
  • 财政年份:
    2009
  • 资助金额:
    $ 18.05万
  • 项目类别:
Angiogenic Signals in Diabetic Complications
糖尿病并发症中的血管生成信号
  • 批准号:
    7896044
  • 财政年份:
    2009
  • 资助金额:
    $ 18.05万
  • 项目类别:
ANGIOTENSIN RECEPTORS/PROSTAGLANDIN E2-REGIONAL BLOOD FLOW IN MOUSE KIDNEY
血管紧张素受体/前列腺素 E2 小鼠肾脏区域血流
  • 批准号:
    7726151
  • 财政年份:
    2008
  • 资助金额:
    $ 18.05万
  • 项目类别:
G-PROTEIN PATHWAYS IN THE KIDNEY TRANSPLANT REJECTION
肾移植排斥反应中的 G 蛋白途径
  • 批准号:
    7486792
  • 财政年份:
    2007
  • 资助金额:
    $ 18.05万
  • 项目类别:
Core A
核心A
  • 批准号:
    7509555
  • 财政年份:
    2007
  • 资助金额:
    $ 18.05万
  • 项目类别:

相似海外基金

Addressing Surgical Disparities at the Root; Working to improve diversity in the surgical workforce
从根本上解决手术差异;
  • 批准号:
    10639471
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
School-Partnered Collaborative Care (SPACE) for Pediatric Type 1 Diabetes
针对儿童 1 型糖尿病的学校合作协作护理 (SPACE)
  • 批准号:
    10640614
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
Feasibility Trial of a Novel Integrated Mindfulness and Acupuncture Program to Improve Outcomes after Spine Surgery (I-MASS)
旨在改善脊柱手术后效果的新型综合正念和针灸计划的可行性试验(I-MASS)
  • 批准号:
    10649741
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
Addressing Gaps in Language Access Services through a Patient-Centered Decision-Support Tool
通过以患者为中心的决策支持工具解决语言获取服务中的差距
  • 批准号:
    10699030
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
Center for Virtual Care Value and Equity (ViVE)
虚拟护理价值和公平中心 (ViVE)
  • 批准号:
    10621602
  • 财政年份:
    2023
  • 资助金额:
    $ 18.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了